<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336440">
  <stage>Registered</stage>
  <submitdate>19/01/2011</submitdate>
  <approvaldate>9/02/2011</approvaldate>
  <actrnumber>ACTRN12611000150943</actrnumber>
  <trial_identification>
    <studytitle>Effect of transnasal insufflation on sleep disordered breathing in acute stroke</studytitle>
    <scientifictitle>Effect of transnasal insufflation on sleep disordered breathing in acute stroke</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>sleep disordered breathing (sleep apnoea)</healthcondition>
    <healthcondition>Acute stroke</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Ischaemic</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The objective of the present study is to assess the tolerance and the efficacy of transnasal insufflation   to treat sleep apnoea in acute stroke patients. Trans-nasal insufflation  is a less invasive method to treat apneas/hypopneas than CPAP. It delivers warm and humidified air at a continuous high flow rate (18 l/min) through an open nasal cannula. It is applied during the one night.</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Reduction of the apnoea/hyponea index during sleep, measured by polysomnography during 1 night</outcome>
      <timepoint>during sleep (1 night)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Sleep parameters: percentages of different sleep stages, number of awakenings, wake after sleep onset, microarousal index, assessed by polysomnography (one night)</outcome>
      <timepoint>during sleep (1 night)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>patients admitted for acute ischemic stroke</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients unable to consent due to the severity of the stroke are excluded</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>10</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Lausanne University Hospital</primarysponsorname>
    <primarysponsoraddress>Lausanne University Hospital 
1011 Lausanne</primarysponsoraddress>
    <primarysponsorcountry>Switzerland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Center for Investigation and Research in Sleep</fundingname>
      <fundingaddress>Lausanne University Hospital 
1011 Lausanne</fundingaddress>
      <fundingcountry>Switzerland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Sleep disordered breathing (SDB) is frequent in acute stroke patients and is associated with early neurologic worsening and poor outcome. Although continuous positive airway pressure (CPAP) effectively treats SDB, compliance is low. The objective of the present study was to assess the tolerance and the efficacy of transnasal insufflation (TNI), a less intrusive method, to treat SDB in acute stroke patients.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Comission cantonale d'ethque pour la recherche (Vaud)</ethicname>
      <ethicaddress>Rue du Bugnon 21
1011 Lausanne</ethicaddress>
      <ethicapprovaldate>7/01/2010</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Switzerland</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jose Haba-Rubio</name>
      <address>Centre d'investigation et de recherche sur le sommeil (CIRS)
CHUV, BH 06, 
1011 Lausanne</address>
      <phone>+  41 21 314 47 69</phone>
      <fax />
      <email>jose.haba-rubio@chuv.ch</email>
      <country>Switzerland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jose Haba-Rubio</name>
      <address>Centre d'investigation et de recherche sur le sommeil (CIRS)
CHUV, BH 06, 
1011 Lausanne</address>
      <phone>+  41 21 314 47 69</phone>
      <fax />
      <email>jose.haba-rubio@chuv.ch</email>
      <country>Switzerland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>